Oorsprong van het eerstegraads netwerk van Motoki Nakai
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Curreio, Inc.
 Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Motoki Nakai via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Biotechnology | Founder | |
| University of Tokyo | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
| Japan | 3 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Operationeel
| Director/Board Member | 2 |
| Founder | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Osamu Nureki | 3 |
- Beurs
- Insiders
- Motoki Nakai
- Bedrijfsconnecties
